Patents Assigned to Adria Laboratories Inc.
  • Patent number: 4831019
    Abstract: Antineoplastic pharmaceutical preparations and a method for treating neoplastic conditions using 4-demethoxy-N-trifluoroacetyldaunomycin and 4-demethoxy-N-trifluoroacetyldoxorubicin.
    Type: Grant
    Filed: May 22, 1985
    Date of Patent: May 16, 1989
    Assignee: Adria Laboratories, Inc.
    Inventors: Richard L. Wolgemuth, John P. Carter
  • Patent number: 4590063
    Abstract: Compounds of the formula ##STR1## where R is a methyl, ethyl or propyl group and n is 1 or 2 and their nontoxic salts are useful as anticonvulsants.
    Type: Grant
    Filed: April 25, 1985
    Date of Patent: May 20, 1986
    Assignee: Adria Laboratories, Inc.
    Inventors: John P. Carter, Jr., Richard L. Wolgemuth
  • Patent number: 4543101
    Abstract: A device for use in equalizing the pressure inside a vial during the addition or removal of fluid comprising a one piece sterilizable device for use in equalizing the pressure inside a vial during the addition or removal of fluid which comprises a cannula having a sharpened beveled lower end for puncturing the septum of a vial, a blunt upper end covered with a septum that can be punctured by the needle of a hypodermic syringe, and an enlarged annular portion below the blunt upper end limiting entry of the device into the vial, said enlarged annular portion having an air channel leading from the inside of the cannula through the enlarged annular portion to the outside of the cannula said air channel being provided at its outer end with means for one-way air flow.
    Type: Grant
    Filed: March 28, 1984
    Date of Patent: September 24, 1985
    Assignee: Adria Laboratories, Inc.
    Inventor: Robert C. Crouch
  • Patent number: 4540814
    Abstract: Compounds of the formula ##STR1## where R is a methyl, ethyl or propyl group and n is 1 or 2 and their nontoxic salts are useful as anticonvulsants.
    Type: Grant
    Filed: June 24, 1983
    Date of Patent: September 10, 1985
    Assignee: Adria Laboratories, Inc.
    Inventors: John P. Carter, Jr., Richard L. Wolgemuth
  • Patent number: 4489206
    Abstract: It has been found that stereospecific R(-)-4-demethoxy-7-deoxydaunomycinone can be synthesized from the known compound 4-demethoxy-7,9-dideoxydaunomycinone. R(-)-4-Demethoxy-7-deoxy-daunomycinone is an intermediate in the synthesis of (+)-4-demethoxydaunomycinone, the aglycone of the nonnaturally occurring and antitumor active (-)7(S)9(S)-4-demethoxydaunorubicin.
    Type: Grant
    Filed: May 13, 1983
    Date of Patent: December 18, 1984
    Assignee: Adria Laboratories, Inc.
    Inventors: Michael P. Cava, Domingo Dominguez
  • Patent number: 4470977
    Abstract: Benzamide derivatives useful as antiemetic or antipsychotic agents are discussed. In the preferred embodiments, administration of the compounds is not accompanied by mammary hypertrophy.
    Type: Grant
    Filed: September 1, 1982
    Date of Patent: September 11, 1984
    Assignee: Adria Laboratories, Inc.
    Inventor: James H. Short
  • Patent number: 4471052
    Abstract: Chemically simplified versions of intermediates on the identified biosynthetic pathway to daunomycin are bioconverted to active analogues of naturally occurring antibiotics.
    Type: Grant
    Filed: January 18, 1982
    Date of Patent: September 11, 1984
    Assignee: Adria Laboratories, Inc.
    Inventors: Lester A. Mitscher, Daniel Lednicer
  • Patent number: 4405522
    Abstract: A synthesis of 5,12-dihydroxy-1,3,4-trihydro-2,6,11-tetracenetrione and its derivatives from leucoquinizarin or a derivative of leucoquinizarin. The tetracenetriones are well-known intermediates in the synthesis of compounds related to doxorubicin.
    Type: Grant
    Filed: January 18, 1982
    Date of Patent: September 20, 1983
    Assignee: Adria Laboratories Inc.
    Inventor: Lester A. Mitscher
  • Patent number: 4395392
    Abstract: A method for decreasing urinary calcium content which comprises orally administering to a person whose urine contains insoluble calcium containing precipitates or has a propensity for forming calcium containing precipitates, an effective amount of an agent selected from water-soluble vinylbenzenesulfonic acid polymers and the nontoxic pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: June 29, 1981
    Date of Patent: July 26, 1983
    Assignee: Adria Laboratories Inc.
    Inventor: Richard L. Wolgemuth
  • Patent number: 4348407
    Abstract: It has been found that fungal diseases can be effectively treated systemically by oral administration of tolciclate or tolnaftate. The drugs will generally be administered in divided daily doses in the form of tablets, capsules, syrups or suspensions.
    Type: Grant
    Filed: April 29, 1981
    Date of Patent: September 7, 1982
    Assignee: Adria Laboratories, Inc.
    Inventors: Anthony R. Imondi, Irving Shemano
  • Patent number: 4316884
    Abstract: It has been found that indoprofen can be used in increased safety at its effective anti-inflammatory dose in humans and that the activity of indoprofen is greatly prolonged by microencapsulating microparticles of indoprofen in a solid protective coating of a cellulose ether such as ethylcellulose.
    Type: Grant
    Filed: June 19, 1980
    Date of Patent: February 23, 1982
    Assignee: Adria Laboratories, Inc.
    Inventors: Abu S. Alam, Herman J. Eichel
  • Patent number: 4223109
    Abstract: The calcium salts of the solid cyclic copolymers of divinyl ether and maleic anhydride, soluble in water, have been found to be as effective in treating tumors and viruses as the prior art alkali metal salts (e.g., the sodium salt) but much less toxic. These copolymers are characterized by containing divinyl ether and maleic anhydride in a mole ratio of about 1:2, having a molecular weight of from about 2000 to about 100,000 and from about 5% to about 70% of its carboxylic acid groups converted to calcium salts.
    Type: Grant
    Filed: February 22, 1979
    Date of Patent: September 16, 1980
    Assignee: Adria Laboratories Inc.
    Inventor: Richard L. Wolgemuth